2B HEALTHY
LIVE

Serial Number

98806296

Owner

Andreas KOPP

Attorney

Tara A. Branscom

Filing Date

Oct 17, 2024

Add to watchlist:

No watchlists yet
View on USPTO

2B HEALTHY Trademark

Serial Number: 98806296

2B HEALTHY is a trademark filed by Andreas KOPP on October 17, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Andreas KOPP

Mühlbachring 22
Bad Aibling 83043 , DE

Entity Type: 01

Trademark Details

Filing Date

October 17, 2024

Registration Date

Not Registered

Published for Opposition

May 27, 2025

Goods & Services

Alcohol for pharmaceutical purposes; Antibacterial pharmaceuticals; Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Bee pollen for use as a dietary food supplement; Bicarbonate of soda for pharmaceutical purposes; Bromine for pharmaceutical purposes; Capsules sold empty for pharmaceuticals; Cardiovascular pharmaceuticals; Cellulose esters for pharmaceutical purposes; Cellulose ethers for pharmaceutical purposes; Charcoal for pharmaceutical purposes; Cream of tartar for pharmaceutical purposes; Creosote for pharmaceutical purposes; Dietary food supplements; Digestives for pharmaceutical purposes; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Enzyme food supplements; Ferments for pharmaceutical purposes; Food supplements; Food supplements, namely, anti-oxidants; Gelatin capsules sold empty for pharmaceuticals; Health food supplements; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Meal for pharmaceutical purposes; Medicated supplements for foodstuffs for animals; Medicated supplements for foodstuffs for babies; Menthol for pharmaceutical purposes; Mineral food supplements; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inducing erections; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperhidrosis; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating halitosis; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in discouraging the smoking habit; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Plant extracts, other than essential oils, for pharmaceutical purposes; Potassium preparations for pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Propolis for pharmaceutical purposes; Turpentine for pharmaceutical purposes

Dispensing of pharmaceuticals; Medical and pharmaceutical consultation; Pharmaceutical advice; Pharmaceutical compounding services; Preparation of prescriptions by pharmacists; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Filing History

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Nov 24, 2025 ETOP
OPPOSITION INSTITUTED NO. 999999
Nov 24, 2025 OP.I
POST PUBLICATION AMENDMENT - ENTERED
Oct 20, 2025 CHPB
ASSIGNED TO PETITION STAFF
Oct 17, 2025 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 11, 2025 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 26, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 27, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 27, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 21, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 29, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 29, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 29, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 29, 2025 CNEA
ASSIGNED TO EXAMINER
Apr 18, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 17, 2025 NWOS
NEW APPLICATION ENTERED
Oct 17, 2024 NWAP